Autolus Therapeutics (AUTL) Ownership - Who owns Autolus Therapeutics?
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AUTL showed earnings on May 08, 2025. You can read more about the earnings report here.